Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.79 |
| ▸ | HPGD | P15428 | 3/20 | 0.79 |
| ▸ | MAPT | P10636 | 3/20 | 0.79 |
| ▸ | GLA | P06280 | 2/20 | 0.79 |
| ▸ | ACHE | P22303 | 2/20 | 0.79 |
| ▸ | NQO2 | P16083 | 3/20 | 0.67 |
| ▸ | HTR3A | P46098 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 2/20 | 0.48 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.48 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19199007 | 0.97 | ALDH1A1 (0.75) | ALDH1A1HPGDMAPTGLAACHE | |
| SCHEMBL13156486 | 0.97 | MAPT (0.83) | ALDH1A1HPGDMAPTGLAACHE | |
| SCHEMBL29379154 | 0.97 | MAPT (0.83) | ALDH1A1HPGDMAPTGLAACHE | |
| SCHEMBL13156489 | 0.92 | MAPT (0.83) | ALDH1A1HPGDMAPTGLAACHE | |
| Anthracene SCHEMBL9879830 | 0.92 | MAPT (0.94) | ALDH1A1HPGDMAPTGLAACHE | |
| SCHEMBL11688588 | 0.92 | NQO2 (0.68) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL1772714 | 0.89 | ALDH1A1 (1.00) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL8339 | 0.89 | ALDH1A1 (1.00) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL29352289 | 0.89 | ALDH1A1 (1.00) | ALDH1A1HPGDMAPTGLAACHE | |
| Acridine SCHEMBL3045498 | 0.89 | ALDH1A1 (1.00) | ALDH1A1HPGDMAPTGLAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1792605-A1 | Use of at least a cationic cyanine derivative for use in hair dyeing, composition containg it process of treating keratinic fibres using the same composition, kit and use thereof | L'Oréal (FR) | 2007-06-06 | — | — | EP | claimed |
| JP-3172522-B2 | — | — | 2001-06-04 | — | — | JP | claimed |
| US-5338847-A | Hydrolytically stable chemiluminescent labels and their conjugates, and assays therefrom by adduct formation | LONDON DIAGNOSTICS, INC. (US) | 1994-08-16 | — | — | US | claimed |
| US-5321136-A | Peri substituted fused ring chemiluminescent labels and their conjugates, and assays therefrom | LONDON DIAGNOSTICS, INC. (US) | 1994-06-14 | — | — | US | claimed |
| US-5290936-A | Indicators or labels for antibodies or medical diagnosis | LONDON DIAGNOSTICS, INC. (US) | 1994-03-01 | — | — | US | claimed |
| US-5284951-A | Aryl ester, thioester or amide of carboxylic acid substituted heterocyclic ring; quaternary compounds | LONDON DIAGNOSTICS, INC. (US) | 1994-02-08 | — | — | US | claimed |
| US-5281712-A | Ammonium substituted chemiluminescent labels and their conjugates, and assays therefrom | LONDON DIAGNOSTICS, INC. (US) | 1994-01-25 | — | — | US | claimed |
| EP-0332190-A2 | Condensed quinoline system compound, condensed acridine system compound, process for preparing the same, and carcinostatic composition containing the same | MECT CORPORATION (JP) | 1989-09-13 | — | — | EP | claimed |
| WO-1989006231-A1 | ASSAYS UTILIZING IMPROVED CHEMILUMINESCENT ESTERS, THIOESTERS AND AMIDES | LONDON DIAGNOSTICS, INC. (US) | 1989-07-13 | — | — | WO | claimed |
| EP-0322926-A2 | Assays utilizing improved chemiluminescent esters, thioesters and amides | LONDON DIAGNOSTICS, INC. (US) | 1989-07-05 | — | — | EP | claimed |
| JP-1228965-A | — | — | None | — | — | JP | disclosed |
| WO-2025096599-A1 | MEASUREMENT OF MULTIPLE ANALYTES USING ACRIDINIUM LABELS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2025-05-08 | — | — | WO | disclosed |
| US-11066351-B2 | Organic compound, three-dimensional organic framework formed by using organic compound, separation sieve and optical layer, which comprise organic framework, and optical device comprising optical layer as optical amplification layer | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) | 2021-07-20 | — | — | US | disclosed |
| US-10862046-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-12-08 | — | — | US | disclosed |
| US-20190031586-A1 | ORGANIC COMPOUND, THREE-DIMENSIONAL ORGANIC FRAMEWORK FORMED BY USING ORGANIC COMPOUND, SEPARATION SIEVE AND OPTICAL LAYER, WHICH COMPRISE ORGANIC FRAMEWORK, AND OPTICAL DEVICE COMPRISING OPTICAL LAYER AS OPTICAL AMPLIFICATION LAYER | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY (KR) | 2019-01-31 | — | — | US | disclosed |
| EP-0332190-A3 | CONDENSED QUINOLINE SYSTEM COMPOUND, CONDENSED ACRIDINE SYSTEM COMPOUND, PROCESS FOR PREPARING THE SAME, AND CARCINOSTATIC COMPOSITION CONTAINING THE SAME | MECT CORPORATION (JP) | 1991-04-24 | — | — | EP | disclosed |
| EP-0332190-A2 | Condensed quinoline system compound, condensed acridine system compound, process for preparing the same, and carcinostatic composition containing the same | MECT CORPORATION (JP) | 1989-09-13 | — | — | EP | disclosed |
| EP-0332190-A2 | Condensed quinoline system compound, condensed acridine system compound, process for preparing the same, and carcinostatic composition containing the same | MECT CORPORATION (JP) | 1989-09-13 | — | — | EP | disclosed |
| JP-H01228965-A | CONDENSED QUINOLINE AND CONDENSED ACRIDINE, THEIR PRODUCTION AND ANTICANCER AGENT CONTAINING SAID COMPOUNDS | MECT CORP | 1989-09-12 | — | — | JP | disclosed |
| EP-0322926-A2 | Assays utilizing improved chemiluminescent esters, thioesters and amides | LONDON DIAGNOSTICS, INC. (US) | 1989-07-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11066351-B2 | Organic compound, three-dimensional organic framework formed by using organic compound, separation sieve and optical layer, which comprise organic framework, and optical device comprising optical layer as optical amplification layer | OR10J3, POF1B, ORC3 | ALDH1A1 2899/4885HPGD 4615/4885MAPT 3445/4885 |
| US-20190031586-A1 | ORGANIC COMPOUND, THREE-DIMENSIONAL ORGANIC FRAMEWORK FORMED BY USING ORGANIC COMPOUND, SEPARATION SIEVE AND OPTICAL LAYER, WHICH COMPRISE ORGANIC FRAMEWORK, AND OPTICAL DEVICE COMPRISING OPTICAL LAYER AS OPTICAL AMPLIFICATION LAYER | OR10J3, POF1B, ORC3 | ALDH1A1 2899/4885HPGD 4615/4885MAPT 3445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.